(XTL) |
| 0 (0%) 06-02 13:08 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 287.87 |
| Resistance 1: | 246.46 |
| Pivot price: | 232.89 |
| Support 1: | 223.44 |
| Support 2: | 209.21 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 29 May 2026
XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat
Wed, 27 May 2026
Trading Systems Reacting to (XTL) Volatility - Stock Traders Daily
Fri, 22 May 2026
XTL Biopharmaceuticals (XTLB) Faces Nasdaq Compliance Challenges Amid Stock Surge - GuruFocus
Fri, 22 May 2026
XTL receives Nasdaq staff delist notice for failing to file annual report - MSN
Fri, 22 May 2026
Nasdaq warns XTL Biopharmaceuticals (NASDAQ: XTLB) on late 20-F and listing defects - Stock Titan
Fri, 22 May 2026
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
